0001012975-23-000525.txt : 20231227 0001012975-23-000525.hdr.sgml : 20231227 20231227155236 ACCESSION NUMBER: 0001012975-23-000525 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 EFFECTIVENESS DATE: 20231227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NGEN-Enzy LP CENTRAL INDEX KEY: 0002005822 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500867 FILM NUMBER: 231517860 BUSINESS ADDRESS: STREET 1: C/O NGEN ENZYMEDICA LLC STREET 2: 775 PARK AVENUE, #7D CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212.450.9704 MAIL ADDRESS: STREET 1: C/O NGEN ENZYMEDICA LLC STREET 2: 775 PARK AVENUE, #7D CITY: NEW YORK STATE: NY ZIP: 10021 D 1 primary_doc.xml X0708 D LIVE 0002005822 NGEN-Enzy LP C/O NGEN ENZYMEDICA LLC 775 PARK AVENUE, #7D NEW YORK NY NEW YORK 10021 212.450.9704 DELAWARE None None Limited Partnership true 2023 N/A NGEN Enzymedica LLC c/o NGEN Enzymedica LLC 775 Park Avenue, #7D New York NY NEW YORK 10021 Director General Partner of the Applicant Shay Murphy 775 Park Avenue, #7D New York NY NEW YORK 10021 Executive Officer Member of the General Partner Peter Grubstein 775 Park Avenue, #7D New York NY NEW YORK 10021 Executive Officer Member of the General Partner Rosemary Ripley 775 Park Avenue, #7D New York NY NEW YORK 10021 Executive Officer Member of the General Partner Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Indefinite 0 Indefinite false 0 0 0 0 true The General Partner will receive a flat fee for management services and a flat transaction fee as specified in the Issuer's partnership agreement. false NGEN-Enzy LP /s/ Shay Murphy Shay Murphy Member of the General Partner 2023-12-27